Researchers make breakthrough in the cause of premature birth

May 30, 2012

(Medical Xpress) -- A significant breakthrough on why women go into labour early or develop the disease  pre-eclampsia has been made by scientists. The discovery concerning the conditions which threaten the life of both the newborn baby and the mother was made by researchers at the Trinity Biomedical Sciences Institute (TBSI) at Trinity College Dublin and Coombe Women and Infants University Hospital.  The findings have just been published in the Journal of Immunology.  

Mothers who deliver their babies early or develop pre-eclampsia have been shown to have higher levels of the baby's DNA in their blood. The researchers have shown that this DNA is seen as foreign by the mother's immune system, being sensed by a protein called Toll-like receptor-9 (TLR9) which provokes an inflammatory reaction that leads to pregnancy loss and early delivery. The research has shown that this response can be blocked by drugs that target TLR9, including chloroquin  − a medicine used in pregnancy for other diseases.

“Premature birth is the biggest cause of infant mortality worldwide. Why babies are born early, as defined as less than 37 weeks gestation, is not known,” explained Professor of Pathology John O'Leary at TCD and the Coombe, senior physician on the research.

“The normal job of TLR9 is to sense DNA from viruses and bacteria. In preterm however, where the baby's DNA enters the mother's blood, TLR9 does mischief causing early birth. Our study makes TLR9 an attractive target to stop preterm birth,” continued Professor of Biochemistry, Luke O'Neill of the School of Biochemistry and Immunology in Trinity Biomedical Sciences Institute and senior scientist.

The work is published in the current issue of the Journal of Immunology, with Dr Andrea Scharfe Nugent, consultant obstetrician and gynaecologist at Mount Carmel Hospital, and microbiologist Dr Sinead Corr as joint lead authors. The research group, which also involves Clinical Professor of Obstetrics and  Gynaecology, Sean Daly, at TCD and consultant in maternal foetal medicine at the  Coombe, and obstetrical clinical lead, are exploring the prospect of developing the discovery for treating women at risk of preterm birth or pre-eclampsia. The research was funded by Science Foundation Ireland and the Friends of the Coombe Hospital.

“This work is an excellent example of Trinity scientists working with clinical colleagues on important medical problems,” concluded Professor O'Neill who is also academic director of the newly opened Trinity Institute.

Explore further: Antidepressants -- not depression -- increase risk of preterm birth, study shows

More information: TLR9 Provokes Inflammation in Response to Fetal DNA: Mechanism for Fetal Loss in Preterm Birth and Preeclampsia. Scharfe-Nugent A, Corr SC, Carpenter SB, Keogh L, Doyle B, Martin C, Fitzgerald KA, Daly S, O'Leary JJ, O'Neill LA. J Immunol. 2012 Jun 1;188(11):5706-12. www.ncbi.nlm.nih.gov/pubmed/22544937

Related Stories

Test for pre-eclampsia developed

May 4, 2011

(Medical Xpress) -- Scientists at King’s have pioneered a new method of identifying early in pregnancy which healthy first-time mothers are at risk of developing pre-eclampsia, a potentially life threatening condition ...

A major step forward in fighting superbugs

July 29, 2011

New research has identified a novel mechanism by which humans can defend themselves against the well known hospital superbug, Clostridium difficile.  The study provides us with critical information for the development ...

Caesarean link to respiratory infections in babies

November 1, 2011

(Medical Xpress) -- A new study from Perth’s Telethon Institute for Child Health Research has found that babies born by elective caesarean are more likely to be admitted to hospital with the serious respiratory infection, ...

Recommended for you

Nature study suggests new therapy for Gaucher disease

February 22, 2017

Scientists propose in Nature blocking a molecule that drives inflammation and organ damage in Gaucher and maybe other lysosomal storage diseases as a possible treatment with fewer risks and lower costs than current therapies.

Understanding how HIV evades the immune system

February 21, 2017

Monash University (Australia) and Cardiff University (UK) researchers have come a step further in understanding how the human immunodeficiency virus (HIV) evades the immune system.

T cells support long-lived antibody-producing cells

February 21, 2017

If you've ever wondered how a vaccine given decades ago can still protect against infection, you have your plasma cells to thank. Plasma cells are long-lived B cells that reside in the bone marrow and churn out antibodies ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.